Development of the first national reference substance of ritonavir as a candidate drug against COVID-19
XIONG Jing, LIU Yi, LIU Zhaoxia, LI Jie, ZHANG Caiyu, WU Xiangxiang, HE Lan
Chinese Journal of Pharmacovigilance . 2022, (2): 137 -141 .  DOI: 10.19803/j.1672-8629.2022.02.06